| case report | Q2782326 |
| scholarly article | Q13442814 |
| P2093 | author name string | Francesco Padula | |
| Alvaro Mesoraca | |||
| Antonella Cima | |||
| Claudio Giorlandino | |||
| Cristiana Brizzi | |||
| Domenico Bizzoco | |||
| Laura D'Emidio | |||
| Luisa Mobili | |||
| Nella Dugo | |||
| Pietro Cignini | |||
| P2860 | cites work | Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy | Q85495453 |
| Position Statement from the Italian College of Fetal Maternal Medicine: Non-invasive prenatal testing (NIPT) by maternal plasma DNA sequencing | Q93588821 | ||
| [Fetal loss after amniocentesis and chorionic villus sampling in Iceland] | Q95566303 | ||
| Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center | Q27007785 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| Incorporating DNA sequencing into current prenatal screening practice for Down's syndrome | Q28488549 | ||
| Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing | Q28742844 | ||
| Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection | Q33268343 | ||
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| Clinical practice. Prenatal screening for aneuploidy | Q34986134 | ||
| Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing | Q35032051 | ||
| Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis | Q35033076 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Prenatal diagnosis: progress through plasma nucleic acids | Q36673937 | ||
| Commercial landscape of noninvasive prenatal testing in the United States | Q37504505 | ||
| Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing | Q37542670 | ||
| A Case of False Negative NIPT for Down Syndrome-Lessons Learned | Q37598581 | ||
| Screening for fetal aneuploidies at 11 to 13 weeks | Q37826399 | ||
| ACMG statement on noninvasive prenatal screening for fetal aneuploidy. | Q38096182 | ||
| Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. | Q38186934 | ||
| Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. | Q39024055 | ||
| Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. | Q39904859 | ||
| Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. | Q39906674 | ||
| First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing | Q43905798 | ||
| Antibiotic prophylaxis before second-trimester genetic amniocentesis (APGA): a single-centre open randomised controlled trial | Q46084560 | ||
| Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis | Q46945516 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Noninvasive Prenatal Detection of Fetal Trisomy 18 by Epigenetic Allelic Ratio Analysis in Maternal Plasma: Theoretical and Empirical Considerations | Q58029492 | ||
| Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities | Q61847809 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 31-35 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Journal of prenatal medicine | Q27723772 |
| P1476 | title | Six consecutive false positive cases from cell-free fetal DNA testing in a single referring centre | |
| P478 | volume | 8 |
| Q88314124 | Biological explanations for discordant noninvasive prenatal test results: Preliminary data and lessons learned |
| Q35065456 | Non-invasive prenatal testing for sex chromosome abnormalities: a source of confusion |
| Q92982636 | Noninvasive Prenatal Testing - When Is It Advantageous to Apply |
| Q41611034 | Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications. |
Search more.